Prolonged treatment of genetically obese mice with conjugated linoleic acid improves glucose tolerance and lowers plasma insulin concentration: possible involvement of PPAR activation
about
Insulin secretion after dietary supplementation with conjugated linoleic acids and n-3 polyunsaturated fatty acids in normal and insulin-resistant mice.Anti-obesity activity of diglyceride containing conjugated linoleic acid in C57BL/6J ob/ob mice.Moderate doses of conjugated linoleic acid reduce fat gain, maintain insulin sensitivity without impairing inflammatory adipose tissue status in mice fed a high-fat dietSuppression of cardiac myocyte hypertrophy by conjugated linoleic acid: role of peroxisome proliferator-activated receptors alpha and gamma.Increased hypolipidemic benefits of cis-9, trans-11 conjugated linoleic acid in combination with trans-11 vaccenic acid in a rodent model of the metabolic syndrome, the JCR:LA-cp rat.Improved glucose tolerance in acyl CoA:diacylglycerol acyltransferase 1-null mice is dependent on diet.Cross-sectional study of conjugated linoleic acid in adipose tissue and risk of diabetesImplication of conjugated linoleic acid (CLA) in human health.Conjugated linoleic acid fails to worsen insulin resistance but induces hepatic steatosis in the presence of leptin in ob/ob mice.A new, highly selective murine peroxisome proliferator-activated receptor δ agonist increases responsiveness to thermogenic stimuli and glucose uptake in skeletal muscle in obese mice.Conjugated Linoleic Acid and Postmenopausal Women's Health.Effects of conjugated linoleic acid plus n-3 polyunsaturated fatty acids on insulin secretion and estimated insulin sensitivity in men.Scientific Opinion on the safety of “conjugated linoleic acid (CLA)-rich oil” (Tonalin® TG 80) as a Novel Food ingredientSynergistic effects of conjugated linoleic acid and chromium picolinate improve vascular function and renal pathophysiology in the insulin-resistant JCR:LA-cp rat.
P2860
Q33224079-506FF85D-0E9E-4D0B-96FC-559A4451AB59Q33569119-CE1120B4-C766-4C9E-B935-188CEA303758Q33702575-F499A6EE-EA8A-4613-B27D-F8488607BF0FQ34751805-6F4882DB-1F64-4918-8470-EABA49912771Q35180157-2BBD3A0E-D7B4-4DB9-8472-EB7937D3FEF2Q35629184-433B6790-E103-4D01-8DFF-D0BAF1D135ABQ36030446-9668C2CB-2F17-4E1B-8A3A-14AA8C4FE610Q37997517-274FFA51-57F6-40B1-AD89-C852F71BBD85Q38297728-86D67990-9C87-43A2-9D9C-319227551D77Q38337776-3DA533D8-B976-44C6-BC8A-4DA434B6CE56Q38473040-AB55EC01-4582-42F5-B2B4-3C30C57EB94BQ44985760-CE18C362-A736-4DC3-8476-D49D940D3EAAQ47148357-DB2AE04B-2F51-47AD-BF4D-2525E3D71F9DQ51482065-3428CD44-3F3E-459D-86D8-F19C970CB541
P2860
Prolonged treatment of genetically obese mice with conjugated linoleic acid improves glucose tolerance and lowers plasma insulin concentration: possible involvement of PPAR activation
description
2005 nî lūn-bûn
@nan
2005 թուականին հրատարակուած գիտական յօդուած
@hyw
2005 թվականին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Prolonged treatment of genetic ...... involvement of PPAR activation
@ast
Prolonged treatment of genetic ...... involvement of PPAR activation
@en
Prolonged treatment of genetic ...... involvement of PPAR activation
@nl
type
label
Prolonged treatment of genetic ...... involvement of PPAR activation
@ast
Prolonged treatment of genetic ...... involvement of PPAR activation
@en
Prolonged treatment of genetic ...... involvement of PPAR activation
@nl
prefLabel
Prolonged treatment of genetic ...... involvement of PPAR activation
@ast
Prolonged treatment of genetic ...... involvement of PPAR activation
@en
Prolonged treatment of genetic ...... involvement of PPAR activation
@nl
P2093
P2860
P356
P1476
Prolonged treatment of genetic ...... involvement of PPAR activation
@en
P2093
Alexandra W C Einerhand
Andrew E Mayes
Claire Stocker
Ed Wargent
Inge Mohede
Jacqueline O'Dowd
Jonathan R S Arch
Louise Brown
Matthew V Sennitt
Michael A Cawthorne
P2860
P2888
P356
10.1186/1476-511X-4-3
P407
P577
2005-01-01T00:00:00Z
P6179
1047907488